---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-001496"
form_type: "8-K"
ticker: "LPTH"
cik: "0000889971"
company_name: "LIGHTPATH TECHNOLOGIES INC"
filed_at: "2024-02-08T23:59:59+00:00"
generated_at: "2026-06-06T06:12:45.489630+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LightPath Q2 FY2024: $7.3M revenue, $1.7M net loss; backlog $21.2M; Lockheed Martin $4.7M order

## Summary
- Revenue $7.3M; net loss $1.7M; EBITDA loss $0.5M for Q2 ended Dec 31, 2023.
- Total backlog $21.2M; received initial $4.7M order from Lockheed Martin partnership for Army infrared camera program.
- Secured renewal order of $3.4M for advanced infrared optics, a 36% increase from initial order.
- Completed $5M expansion of Orlando facility, increasing footprint from 34,000 to 55,000 sq ft.
- CEO: production decision for Lockheed Martin program moved to 2026; ASP $5K-$10K per system; potential tens of thousands of units.

## SEC filing metadata
- accession: 0001654954-24-001496
- form_type: 8-K
- ticker: LPTH
- cik: 0000889971
- company_name: LIGHTPATH TECHNOLOGIES INC
- filed_at: 2024-02-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/889971/000165495424001496/0001654954-24-001496-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/889971/000165495424001496/lpth_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-001496
- JSON: https://secwatch.observer/filing/0001654954-24-001496.json
- Plain text: https://secwatch.observer/filing/0001654954-24-001496.txt

## Key facts
- Earnings Releases
  LIGHTPATH TECHNOLOGIES INC reported fiscal 2024 second quarter ended December 31, 2023 results: revenue Revenue of $7.3 million, net income Net loss for the second quarter of fiscal 2024 was $1.7 million.
  - Period: fiscal 2024 second quarter ended December 31, 2023
  - Revenue: Revenue of $7.3 million
  - Net income: Net loss for the second quarter of fiscal 2024 was $1.7 million
  - Result: reported results
  source text: and medical industries, today announced financial results for its fiscal 2024 second quarter ended December 31, 2023. Fiscal 2024 Second Quarter Highlights: · Revenue of $7.3 million for the second quarter of fiscal 2024 · Total backlog at December 31, 2023 of $21.2 million · Net loss for the second quarter of fiscal 2024 was $1.7 million · EBITDA* loss for
  evidence_url: https://www.sec.gov/Archives/edgar/data/889971/000165495424001496/0001654954-24-001496-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.